These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6410211)

  • 21. The 'Alice in Wonderland' experience. Ergot alkaloid therapy for prolactin-secreting pituitary tumors.
    Williams RC; Sherman C; Buckman MT
    West J Med; 1983 Mar; 138(3):391-7. PubMed ID: 6858128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
    Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The history and pharmacology of dopamine agonists.
    Lataste X
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):118-23. PubMed ID: 6713309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibition of prolactin by an ergot-alkaloid derivative].
    Wenner R; Varga L
    Gynakol Rundsch; 1973; 13():Suppl 1:64-5. PubMed ID: 4798936
    [No Abstract]   [Full Text] [Related]  

  • 25. Sclerosing mesenteritis: an ergot-related complication of pergolide therapy in Parkinson's disease?
    Bharucha KJ; Blevins SM
    Mov Disord; 2008 Apr; 23(6):922-3. PubMed ID: 18361473
    [No Abstract]   [Full Text] [Related]  

  • 26. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
    Kim JY; Chung EJ; Park SW; Lee WY
    Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromocriptine in Parkinsonism.
    Calne DB; Teychenne PF; Claveria LE; Eastman R; Greenacre JK; Petrie A
    Br Med J; 1974 Nov; 4(5942):442-4. PubMed ID: 4425916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic and antidyskinetic properties of ergot dopamine agonists.
    Tamminga CA
    Adv Biochem Psychopharmacol; 1980; 23():397-403. PubMed ID: 7395624
    [No Abstract]   [Full Text] [Related]  

  • 29. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prolactinoma].
    van Leusden HA; Booij D
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):97-9. PubMed ID: 7374837
    [No Abstract]   [Full Text] [Related]  

  • 32. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
    Horowski R
    Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prescription of ergot derivatives for lactation inhibition in France: Current practices].
    Mirkou A; Suchovsky D; Gouraud A; Gillet A; Bernard N; Descotes J; Vial T
    J Gynecol Obstet Biol Reprod (Paris); 2012 Apr; 41(2):167-73. PubMed ID: 22000685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of prolactin producing pituitary adenomas.
    Randall RV
    Trans Am Clin Climatol Assoc; 1982; 93():209-16. PubMed ID: 7345716
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of ergot derivative lisuride in Parkinson's disease.
    Suchy I; Horowski R
    Adv Neurol; 1984; 40():515-21. PubMed ID: 6695629
    [No Abstract]   [Full Text] [Related]  

  • 37. Paternity after bromocriptine therapy for hyperprolactinemia.
    Siegel AJ; Federman DD
    N Engl J Med; 1984 Sep; 311(13):859-60. PubMed ID: 6472391
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of prolactinoma with bromocriptine].
    Dtsch Med Wochenschr; 1983 Jan; 108(1):39. PubMed ID: 6848347
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence for a physiological role of prolactin in osmoregulation in the rat after its inhibition by 2-bromo- -ergokryptine.
    Richardson BP
    Br J Pharmacol; 1973 Mar; 47(3):623P-624P. PubMed ID: 4730843
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hyperprolactinemias: physiopathological, clinical and therapeutic considerations].
    de Lima GR
    Rev Paul Med; 1983; 101(3):103-6. PubMed ID: 6417759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.